Private Label Centella Asiatica Moisturizer Manufacturer Low MOQ

Can I sell a private label centella asiatica moisturizer in both the US and EU?

By Blake Mereby · Last reviewed October 5, 2026

Yes, but dual-market compliance requires deliberate formulation and regulatory planning from day one — retrofitting a US-only formula for EU compliance later is expensive and often means reformulation.

In the United States, centella asiatica moisturizers are regulated as cosmetics under the FDA and, since 2023, under the Modernization of Cosmetics Regulation Act (MoCRA). MoCRA requires facility registration by the manufacturer (not you, unless you're also manufacturing), product listing with FDA, adverse event reporting procedures, and good manufacturing practice compliance. Centella asiatica is not a restricted substance in the US, and there is no pre-market approval requirement. The key compliance risk is claim language: anything that implies a drug effect ("heals wounds," "treats eczema," "clinically repairs the skin barrier") can trigger FDA drug classification. Stick to cosmetic language ("supports a healthy-looking skin barrier," "soothes the appearance of redness").

In the European Union, cosmetics are regulated under EC Regulation 1223/2009. Every cosmetic placed on the EU market must have a designated Responsible Person (RP) established in the EU, a complete Product Information File (PIF), and a Cosmetic Product Safety Report (CPSR) authored by a qualified safety assessor. The preservative system in your formula must comply with Annex V of the EU Cosmetics Regulation — some preservatives used freely in US formulas (certain parabens at specific concentrations, for example) are restricted or banned in the EU. Fragrance allergen disclosure is also mandatory in the EU for 26 listed allergens at threshold concentrations.

For a dual-US/EU launch, the practical steps are: (1) instruct your cosmetic chemist to formulate with EU Annex V-compliant preservatives from the start; (2) confirm all fragrance components are IFRA-compliant and EU allergen disclosable; (3) build the PIF documentation (INCI list, stability data, challenge test results, CoA for all raw materials) as part of your standard development package, not as an afterthought; (4) appoint an EU Responsible Person before any product enters the EU market.

California's Proposition 65 is a third layer to watch: if any botanical extract constituent in your formula (at finished-product exposure levels) appears on the Prop 65 list, you need a warning or a quantitative risk assessment showing exposure is below the no-significant-risk level. Ask your manufacturer's toxicologist to screen your full INCI list.

AJ Cosmo Labs connects founders with formulators and regulatory consultants experienced in dual-market cosmetic compliance, so you can brief this requirement alongside your formula specs rather than discovering the gap after production.

Read the full guide on Private Label Centella Asiatica Moisturizer Manufacturer Low MOQ →

More about Private Label Centella Asiatica Moisturizer Manufacturer Low MOQ

Tell us about your product

Tell us what you're selling and where. You can hire a vetted cosmetic chemist on AJ Cosmo Labs to review your formula and labeling. Starting is free.

Free to start · no credit card · continue in your browser or the iPhone app.

Have a product idea?

Connect with vetted cosmetic chemists and custom labs on AJ Cosmo Labs.

Get on the App Store Open the web app